검색
검색 팝업 닫기

Ex) Article Title, Author, Keywords

JKFN Journal of the Korean Society of Food Science and Nutrition



Online ISSN 2288-5978

Article

home All Articles View

Article

Split Viewer

Journal of the Korean Society of Food Science and Nutrition 2013; 42(2): 244-248

Published online February 28, 2013

Copyright © The Korean Society of Food Science and Nutrition.

Confirmation of Schizandrin as a Marker Compound in Jangsu Omija Powder

Yunjeong Kim1,2, Na Ha1,2, Song-Hee Han1,2, Ji-Young Jeon1,2, Minho Hwang1,2,Yong-Jin Im1,2, Sun Young Lee1,3, Soo-Wan Chae1,2,4, and Min-Gul Kim1,2

1Biomedical Research Institute, 2Clinical Trial Center, and 3Dept. of Radiatio Oncology, Chonbuk National University Hospital, Jeonbuk 561-712, Korea; 4Dept. of Pharmacology, Chonbuk National University Medical School, Jeonbuk 561-712, Korea

Abstract

We studied the development of schizandrin as a marker compound in Jangsu Omija. Schizandrin was validated for its LOD (limit of detection), LOQ (limit of quantitation), precision, accuracy, and recovery by HPLC relative to Omija powder. It showed a high linearity in the calibration curve with a coefficient of correlation (R2) of 0.9990. The LOD and LOQ were 0.2 μg/mL and 0.5 μg/mL, respectively. The intra- and inter-day precision of schizandrin calibration standards was 0.06~0.66% and 0.13~1.19%, respectively, and the intra- and inter-day accuracy of schizandrin was 98.35~103.30% and 98.35~103.00%, respectively. Overall, schizandrin was validated through our analytical methods as a marker compound in Jangsu Omija.

Keywords: schizandrin, method development, Omija, HPLC, validation

Article

Article

Journal of the Korean Society of Food Science and Nutrition 2013; 42(2): 244-248

Published online February 28, 2013

Copyright © The Korean Society of Food Science and Nutrition.

HPLC를 이용한 기능성 원료 지표성분으로서 장수 오미자 분말 중 Schizandrin의 분석법 개발

Confirmation of Schizandrin as a Marker Compound in Jangsu Omija Powder

Yunjeong Kim*1*,*2*, Na Ha*1*,*2, Song-Hee Han*1*,*2, Ji-Young Jeon*1*,*2, Minho Hwang*1*,*2,Yong-Jin Im*1*,*2, Sun Young Lee*1*,*3, Soo-Wan Chae*1*,*2*,*4, and Min-Gul Kim*1*,*2

*1Biomedical Research Institute, *2Clinical Trial Center, and *3Dept. of Radiatio Oncology, Chonbuk National University Hospital, Jeonbuk 561-712, Korea; *4Dept. of Pharmacology, Chonbuk National University Medical School, Jeonbuk 561-712, Korea

Abstract

We studied the development of schizandrin as a marker compound in Jangsu Omija. Schizandrin was validated for its LOD (limit of detection), LOQ (limit of quantitation), precision, accuracy, and recovery by HPLC relative to Omija powder. It showed a high linearity in the calibration curve with a coefficient of correlation (R2) of 0.9990. The LOD and LOQ were 0.2 μg/mL and 0.5 μg/mL, respectively. The intra- and inter-day precision of schizandrin calibration standards was 0.06~0.66% and 0.13~1.19%, respectively, and the intra- and inter-day accuracy of schizandrin was 98.35~103.30% and 98.35~103.00%, respectively. Overall, schizandrin was validated through our analytical methods as a marker compound in Jangsu Omija.

Keywords: schizandrin, method development, Omija, HPLC, validation